Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

14 Jul 2022 07:00

RNS Number : 4114S
Xaar PLC
14 July 2022
 

 

Xaar plc

 

Trading Update

 

Xaar plc ("Xaar", the "Group" or the "Company"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2022.

 

 

TRADING

 

Continued strong trading and momentum

 

· Revenue for the period is expected to be approximately £37 million, representing an increase of 41% relative to H1 2021 (14% organic excluding FFEI and Megnajet) and 12% relative to H2 2021 (11% organic excluding Megnajet)

 

· Strong revenue growth with improved gross margins and successful cost management actions mean the Board expects the Group to be on track to report an adjusted profit for the current year in line with its expectations

 

Further operational and strategic progress across the Group

 

· Printhead division performed well with strong growth in Europe and US offsetting a Covid-related slowdown in China. We remain on track for the aqueous printhead launch in Q4 2022

 

· The new printbar product developed by FFEI, Xaar Versatex, was successfully launched, whilst the acquisition of Megnajet further strengthens the Group's vertical integration capability

 

· Product Print Systems business ("EPS") delivered a strong, improved performance with revenue and margin growth

 

Successfully mitigating cost inflation

 

· Further investment in inventory has allowed the Group to successfully mitigate cost inflation and increases supply chain resilience

 

· Sales price increases have further assisted in off-setting the effects of cost inflation

 

· Additional management initiatives are helping in reducing costs and increasing operational efficiency while cutting energy use supporting Xaar's 'net zero' commitments

 

 

BALANCE SHEET AND LIQUIDITY

 

The Group remains well capitalised with a strong balance sheet and cash position. Investment has been made in acquiring Megnajet and key capital projects together with increasing working capital to protect the Group's supply chain and ability to deliver products on time. Net cash at 30 June 2022, was £12.6 million, in line with management expectations.

 

 

John Mills, Chief Executive Officer, commented:

 

"We are really pleased to have achieved a strong performance in the first half of the year in line with our expectations. We are on target, seeing positive momentum continuing to improve performance across the Group.

 

We continue to make strategic and operational progress and remain on track to delivering long-term profitable growth.

 

Despite a continued uncertain macro-economic outlook, we remain confident and excited by the future and look forward to the launch of our aqueous printhead later in the year." 

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Tulchan Communications

Giles Kernick

Olivia Lucas

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKNBKCBKDCOD
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.